Literature DB >> 2882776

Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentrations and their dissipation profile.

A Ohnishi, A Minegishi, T Sasaki, T Suganuma, T Ishizaki.   

Abstract

The time-course of plasma noradrenaline (NA) and adrenaline (A) concentrations and their dissipation profiles were examined concomitantly with heart rate changes after strenuous exercise in eight normal subjects receiving either placebo or carteolol, a beta-adrenoceptor blocker. Post-exercise NA concentrations declined with time in a biexponential manner, while A disappearance curves were apparently monophasic. Plasma NA concentrations and their peak value attained within 3 min after exercise were higher in the carteolol than in the placebo phase, whereas there were no significant differences in the first and second disappearance t1/2 between the two trials. The monoexponential t1/2 of A in the carteolol trial was significantly longer than in the placebo trial. Our results suggest that the dissipation profiles of catecholamines released by exercise appear to be affected by beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882776      PMCID: PMC1386233          DOI: 10.1111/j.1365-2125.1987.tb03054.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

Review 1.  Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.

Authors:  P E Cryer
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

2.  Disappearance of norepinephrine from the circulation following strenuous exercise.

Authors:  J M Hagberg; R C Hickson; J A McLane; A A Ehsani; W W Winder
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-12

3.  Enhanced plasma norepinephrine response to upright posture and oral glucose administration in elderly human subjects.

Authors:  J B Young; J W Rowe; J A Pallotta; D Sparrow; L Landsberg
Journal:  Metabolism       Date:  1980-06       Impact factor: 8.694

4.  Effects of beta adrenergic blockade on plasma catecholamines in exercise.

Authors:  M H Irving; B J Britton; W G Wood; C Padgham; M Carruthers
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

5.  Effect of propranolol on noradrenaline kinetics in patients with essential hypertension.

Authors:  M Esler; G Jackman; P Leonard; H Skews; A Bobik; G Jennings
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

6.  Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection.

Authors:  I N Mefford; M M Ward; L Miles; B Taylor; M A Chesney; D L Keegan; J D Barchas
Journal:  Life Sci       Date:  1981-02-02       Impact factor: 5.037

7.  Interindividual variation in kinetics of infused epinephrine.

Authors:  G A FitzGerald; V Hossmann; C A Hamilton; J L Reid; D S Davies; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

8.  Concentration-effect and time-effect relationships of carteolol.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Chiba; T Suganuma; K Kushida
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Effect of norepinephrine uptake blockers on norepinephrine kinetics.

Authors:  M Esler; G Jackman; P Leonard; H Skews; A Bobik; P Korner
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

10.  Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.

Authors:  P E Cryer; R A Rizza; M W Haymond; J E Gerich
Journal:  Metabolism       Date:  1980-11       Impact factor: 8.694

View more
  2 in total

Review 1.  Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.

Authors:  Y Yamada; K Matsuyama; K Ito; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

2.  In vivo desensitization of glycogenolysis to Ca2+-mobilizing hormones in rat liver cells.

Authors:  G Tsujimoto; A Tsujimoto; K Kato; K Hashimoto
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.